Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML [Phase 1]
Phase 1 trial evaluating allogeneic stem cell transplantation in high-risk CD33+ acute myeloid leukemia, myelodysplastic syndrome, and juven…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants [Phase 2]
A Phase 2 clinical trial evaluating a sirolimus-tacrolimus combination following HLA-matched related peripheral blood stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome [Phase 2]
A Phase 2 study evaluating the combination of valproic acid and lenalidomide for myelodysplastic syndrome has been terminated; the update di…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Haploid Allogeneic Transplant Using the CliniMACS System [Phase 2]
A Phase 2 clinical trial evaluating haploid allogeneic transplantation using the CliniMACS System was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) [Phase 2]
Phase II clinical trial evaluating a combination of idarubicin, cytarabine, and vorinostat in high-risk myelodysplastic syndrome and acute m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome [Phase 2]
A Phase 2 trial of KRN321 in adults with myelodysplastic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies [Phase 1]
Phase 1 trial of Actinium-225-labeled HuM195 (lintuzumab) for advanced myeloid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Temsirolimus in Myelodysplastic Syndrome (MDS) [Phase 2]
A Phase 2 clinical trial evaluating temsirolimus for myelodysplastic syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients [Phase 2]
A Phase 2 safety and efficacy study of AS101 for elderly patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome has been suspende…
-
CLINICAL_TRIALS trial_result · 2015-01-28Clinical Trial Update: Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients [Phase 1]
Phase 1 bioequivalence study of azacitidine for injection in myelodysplastic syndrome patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY [Phase 1, Phase 2]
This update covers an allogeneic bone marrow transplant using matched related or unrelated donors with FluBu conditioning and HiCy (high-dos…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)
This trial update reports serial analysis of donor chimerism in pediatric patients with refractory cytopenia of childhood who underwent redu…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Phase 1, Phase 2]
This completed Phase 1/2 clinical trial evaluated a conditioning regimen using Clofarabine and Busulfan for hematologic malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Stem Cell Transplantation for Patients With Cancers of the Blood [Phase 2]
Phase 2 trial update reporting results from stem cell transplantation for patients with blood cancers, including chronic myeloid leukemia, c…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants [Phase 2]
Phase 2 clinical trial update on methods to enhance safety and effectiveness of stem cell transplants.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases [Phase 1]
Phase 1 trial update on belinostat plus azacitidine in adults with advanced hematologic cancers. The study has completed enrollment and eval…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1]
This document reports the completion of a Phase 1 safety study of lintuzumab in patients with acute myeloid leukemia and myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps [Phase 1, Phase 2]
This Phase 1/2 study evaluated a two-step reduced-intensity conditioning regimen for bone marrow transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS [Phase 2]
Phase 2 open-label, multi-dose study of Panhematin in patients with myelodysplastic syndrome was terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia [Phase 2]
A Phase 2 trial evaluated antithymocyte globulin plus cyclosporine for myelodysplastic syndrome; the study is completed with results posted …
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome [Phase 2]
A Phase 2 trial comparing siltuximab plus best supportive care to placebo plus best supportive care in anemic patients with IPSS low- or int…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant [NA]
This clinical trial update reports the completion and results posting of a study evaluating pre-transplant treatment with 5-azacitidine in p…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers [Phase 2]
Phase 2 clinical trial update evaluating peptide vaccinations in patients with low-risk myeloid cancers, including myelodysplastic syndrome …
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy [Phase 2]
Phase 2 trial of WT1 peptide vaccine in high-risk hematologic malignancies (myelodysplastic syndrome, acute myeloid leukemia, and chronic my…